Management Comments "Fiscal 2025 was a transformative year for Azenta. We achieved 3% core revenue growth and meaningful margin expansion," said John Marotta, President and Chief Executive Officer.

Azenta’s defensive Russell inclusion highlights its life sciences role, service growth plan, margin pressure, and ...

Azenta (NASDAQ:AZTA) is preparing to release its quarterly earnings on Tuesday, 2024-11-12. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect ...

Evercore ISI raised the firm’s price target on Azenta (AZTA) to $50 from $48 and keeps an In Line rating on the shares. In the firm’s 2025 outlook note for MedTech, Life Science Tools and Diagnostics, ...

Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) -Activist investor Politan Capital Management has nominated candidates to Azenta's board and is working with the ...

What a brutal six months it’s been for Azenta. The stock has dropped 30.3% and now trades at $24, rattling many shareholders. This was partly due to its softer quarterly results and might have ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

NYSE: DCO: $16 million (6.8% of AUM) NYSE: PLYM: $14.6 million (6.2% of AUM) NASDAQ: MGNI: $13.4 million (5.7% of AUM) NYSE: SEI: $11.7 million (5% of AUM) NASDAQ: PLAB: $11.6 million (4.9% of AUM) As ...

On November 4, 2025, the PRECEDE Foundation announced a partnership with Azenta to provide secure biorepository storage and logistics for its pancreatic cancer early detection studies. This ...